Want to join the conversation?
On Oct. 28, $ICPT announced results of a 72-week Phase 2 dose ranging trial of OCA in 200 adult patients with NASH in Japan. In this trial, 202 Japanese biopsy-proven NASH patients were randomized into one of four arms to receive either a 10mg, 20mg or 40mg dose of OCA or placebo. The primary endpoints was histologic improvement.
$AAL is giving pay hikes to its employees but investors are sulking.
$APC stock tumbled more than 5.6% after last week's fatal home explosion in Firestone, Colorado prompted the company to close more than 3,000 wells for weeks.
Unicorn Frappuccino. The latest hit from $SBUX. Can't wait to see how this will affect its results.
At what point should $AMZN consider a stock split? $1000 per share seems pretty high.